Dysregulation of claudin-7 leads to loss of E-cadherin expression and the increased invasion of esophageal squamous cell carcinoma cells

American Journal of Pathology

Volumn 170, Issue 2, 2007, Pages 709-721

  Lioni, Mercedes ^a   Brafford, Patricia ^a   Andl, Claudia ^b   Rustgi, Anil ^b   El Deiry, Wafik ^b   Herlyn, Meenhard ^a   Smalley, Keiran S M ^a  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN 1; CLAUDIN 4; CLAUDIN 7; SMALL INTERFERING RNA; UVOMORULIN; CADHERIN; CLDN7 PROTEIN, HUMAN; MEMBRANE PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CANCER INVASION; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR UPREGULATION; BIOSYNTHESIS; CELL TRANSFORMATION; DRUG ANTAGONISM; DRUG EFFECT; ESOPHAGUS; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; METABOLISM; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

CADHERINS; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KERATINOCYTES; MEMBRANE PROTEINS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; RNA, SMALL INTERFERING;

EID: 33947547489     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.060343     Document Type: Article

References (44)

1. Haass NK, Smalley KS, Herlyn M: The role of altered cell-cell communication in melanoma progression. J Mol Histol 2004, 35:309-318
2. Tsukita S, Furuse M: Pores in the wall: claudins constitute tight junction strands containing aqueous pores. J Cell Biol 2000, 149:13-16
3. Morin PJ: Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res 2005, 65:9603-9606
4. Smalley KS, Brafford P, Haass NK, Brandner JM, Brown E, Herlyn M: Up-regulated expression of zonula occludens protein-1 in human melanoma associates with N-cadherin and contributes to invasion and adhesion. Am J Pathol 2005, 166:1541-1554
5. Stevenson BR, Anderson JM, Goodenough DA, Mooseker MS: Tight junction structure and ZO-1 content are identical in two strains of Madin-Darby canine kidney cells which differ in transepithelial resistance. J Cell Biol 1988, 107:2401-2408
6. Anderson JM, Stevenson BR, Jesaitis LA, Goodenough DA, Mooseker MS: Characterization of ZO-1, a protein component of the tight junction from mouse liver and Madin-Darby canine kidney cells. J Cell Biol 1988, 106:1141-1149
7. Peacock RE, Keen TJ, Inglehearn CF: Analysis of a human gene homologous to rat ventral prostate.1 protein. Genomics 1997, 46:443-449
8. Itoh M, Furuse M, Morita K, Kubota K, Saitou M, Tsukita S: Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J Cell Biol 1999, 147:1351-1363
9. Morita K, Furuse M, Fujimoto K, Tsukita S: Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc Natl Acad Sci USA 1999, 96:511-516
10. Turksen K, Troy TC: Barriers built on claudins. J Cell Sci 2004, 117:2435-2447
11. Al Moustafa AE, Alaoui-Jamali MA, Batist G, Hernandez-Perez M, Serruya C, Alpert L, Black MJ, Sladek R, Foulkes WD: Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene 2002, 21:2634-2640
12. Kominsky SL, Argani P, Korz D, Evron E, Raman V, Garrett E, Rein A, Sauter G, Kallioniemi OP, Sukumar S: Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 2003, 22:2021-2033
13. Resnick MB, Konkin T, Routhier J, Sabo E, Pricolo VE: Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study. Mod Pathol 2005, 18:511-518
14. Michl P, Barth C, Buchholz M, Lerch MM, Rolke M, Holzmann KH, Menke A, Fensterer H, Giehl K, Lohr M, Leder G, Iwamura T, Adler G, Gress TM: Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. Cancer Res 2003, 63:6265-6271
15. Hoevel T, Macek R, Swisshelm K, Kubbies M: Reexpression of the TJ protein CLDN1 induces apoptosis in breast tumor spheroids. Int J Cancer 2004, 108:374-383
16. Rangel LB, Agarwal R, D'Souza T, Pizer ES, Alo PL, Lancaster WD, Gregoire L, Schwartz DR, Cho KR, Morin PJ: Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian oystadenomas. Clin Cancer Res 2003, 9:2567-2575
17. Gress TM, Muller-Pillasch F, Geng M, Zimmerhackl F, Zehetner G, Friess H, Buchler M, Adler G, Lehrach H: A pancreatic cancer-specific expression profile. Oncogene 1996, 13:1819-1830
18. Kominsky SL, Vali M, Korz D, Gabig TG, Weitzman SA, Argani P, Sukumar S: Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4. Am J Pathol 2004, 164:1627-1633
19. Long H, Crean CD, Lee WH, Cummings OW, Gabig TG: Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium. Cancer Res 2001, 61:7878-7881
20. Agarwal R, D'Souza T, Morin PJ: Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity. Cancer Res 2005, 65:7378-7385
21. Andl CD, Mizushima T, Nakagawa H, Oyama K, Harada H, Chruma K, Herlyn M, Rustgi AK: Epidermal growth factor receptor mediates increased cell proliferation, migration, and aggregation in esophageal keratinocytes in vitro and in vivo. J Biol Chem 2003, 278:1824-1830
22. Harada H, Nakagawa H, Oyama K, Takaoka M, Andl CD, Jacobmeier B, von Werder A, Enders GH, Opitz OG, Rustgi AK: Telomerase induces immortalization of human esophageal keratinocytes without p16INK4a inactivation. Mol Cancer Res 2003, 1:729-738
23. Hsu MY, Meier FE, Nesbit M, Hsu JY, Van Belle P, Elder DE, Herlyn M: E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am J Pathol 2000, 156:1515-1525
24. de Martin R, Raidl M, Hofer E, Binder BR: Adenovirus-mediated expression of green fluorescent protein. Gene Ther 1997, 4:493-495
25. Elbashir SM, Harborth J, Weber K, Tuschl T: Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 2002, 26:199-213
26. Smalley KS, Haass NK, Brafford PA, Lioni M, Flaherty KT, Herlyn M: Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases. Mol Cancer Ther 2006, 5:1136-1144
27. Oku N, Sasabe E, Ueta E, Yamamoto T, Osaki T: Tight junction protein claudin-1 enhances the invasive activity of oral squamous cell carcinoma cells by promoting cleavage of laminin-5 gamma2 chain via matrix metalloproteinase (MMP)-2 and membrane-type MMP-1. Cancer Res 2006, 66:5251-5257
28. Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C, Bissell MJ: Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 1997, 137:231-245
29. Cukierman E, Pankov R, Stevens DR, Yamada KM: Taking cell-matrix adhesions to the third dimension. Science 2001, 294:1708-1712
30. Dhawan P, Singh AB, Deane NG, No Y, Shiou SR, Schmidt C, Neff J, Washington MK, Beauchamp RD: Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J Clin Invest 2005, 115:1765-1776
31. Tokés AM, Kulka J, Paku S, Szik A, Paska C, Novak PK, Szilak L, Kiss A, Bogi K, Schaff Z: Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res 2005, 7:R296-R305
32. Fujibe M, Chiba H, Kojima T, Soma T, Wada T, Yamashita T, Sawada N: Thr203 of claudin-1, a putative phosphorylation site for MAP kinase, is required to promote the barrier function of tight junctions. Exp Cell Res 2004, 295:36-47
33. Banan A, Zhang LJ, Shaikh M, Fields JZ, Choudhary S, Forsyth CB, Farhadi A, Keshavarzian A: Theta Isoform of protein kinase C alters barrier function in intestinal epithelium through modulation of distinct claudin isotypes: a novel mechanism for regulation of permeability. J Pharmacol Exp Ther 2005, 313:962-982
34. D'Souza T, Agarwal R, Morin PJ: Phosphorylation of claudin-3 at threonine 192 by cAMP-dependent protein kinase regulates tight junction barrier function in ovarian cancer cells. J Biol Chem 2005, 280:26233-26240
35. Yamauchi K, Rai T, Kobayashi K, Sohara E, Suzuki T, Itoh T, Suda S, Hayama A, Sasaki S, Uchida S: Disease-causing mutant WNK4 increases paracellular chloride permeability and phosphorylates claudins. Proc Natl Acad Sci USA 2004, 101:4690-4694
36. Tanaka M, Kamata R, Sakai R: EphA2 phosphorylates the cytoplasmic tail of claudin-4 and mediates paracellular permeability. J Biol Chem 2005, 280:42375-42382
37. Lee JW, Lee SJ, Seo J, Song SY, Ahn G, Park CS, Lee JH, Kim BG, Bae DS: Increased expressions of claudin-1 and claudin-7 during the progression of cervical neoplasia. Gynecol Oncol 2005, 97:53-59
38. Cheung ST, Leung KL, Ip YC, Chen X, Fong DY, Ng IO, Fan ST, So S: Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma. Clin Cancer Res 2005, 11:551-556
39. Medici D, Hay ED, Goodenough DA: Cooperation between Snail and LEF-1 transcription factors is essential for TGF-beta1-induced epithelial-mesenchymal transition. Mol Biol Cell 2006, 17:1871-1879
40. Hajra KM, Fearon ER: Cadherin and catenin alterations in human cancer. Genes Chromosom Cancer 2002, 34:255-268
41. Guilford P: E-cadherin downregulation in cancer: fuel on the fire? Mol Med Today 1999, 5:172-177
42. Martínez-Estrada OM, Culleres A, Soriano FX, Peinado H, Bolos V, Martinez FO, Reina M, Cano A, Fabre M, Vilaro S: The transcription factors Slug and Snail act as repressors of claudin-1 expression in epithelial cells. Biochem J 2006, 394:449-457
43. Uchikado Y, Natsugoe S, Okumura H, Setoyama T, Matsumoto M, Ishigami S, Aikou T: Slug expression in the E-cadherin preserved tumors is related to prognosis in patients with esophageal squamous cell carcinoma. Clin Cancer Res 2005, 11:1174-1180
44. Arabzadeh A, Troy TC, Turksen K: Role of the cldn6 cytoplasmic tail domain in membrane targeting and epidermal differentiation in vivo. Mol Cell Biol 2006, 26:5876-5887